drugset / Trial / NCT05904028
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Phase 3
Active not recruiting
603 enrolled
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation · collabNational Eye Institute (NEI) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
Home optical coherence tomography- guided treatment versus treat and extend for the management of neovascular age-related macular degeneration.
Timeline
- Start
- 2023-11-09
- Primary completion
- 2027-07-30
- Completion
- 2027-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Faricimab | Monoclonal antibody | 6 mg | Intravitreal |